Cargando…
(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging
BACKGROUND: Breast cancer is the most common malignancy among women in the world. Development of novel tumor-specific radiopharmaceuticals for early breast tumor diagnosis is highly desirable. In this study we developed (99m)Tc-HYNIC-(tricine/EDDA)-Lys-FROP peptide with the ability of specific bindi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817723/ https://www.ncbi.nlm.nih.gov/pubmed/29455647 http://dx.doi.org/10.1186/s12929-018-0420-x |